newsfilter
← Latest News
PR Newswire·

Aeglea BioTherapeutics Announces Grant of Inducement Awards

AUSTIN, Texas and WALTHAM, Mass., June 23, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ:AGLE) today announced that, in connection with the acquisition of Spyre Therapeutics, Inc.